The Health Bank to Partner with Nanotronics Health, LLC, to Distribute Low-Cost, US-Manufactured Non-Invasive Ventilator for Respiratory Support During COVID-19 Pandemic

Dubai, United Arab Emirates: 

Salman Arif, the CEO of The Health Bank (THB) Global, announced today that the company is partnering with Nanotronics Health, LLC, to distribute nHale^TM, a non-invasive ventilator. It will be distributed in the Middle East, North Africa and South Asia (MENASA) region. To support non-invasive respiratory therapy in the region, The Health Bank will also train medical professionals to operate the device.

“In pursuit of finding a solution for managing COVID-19 symptoms through non-invasive methods, we have partnered with Nanotronics Health, LLC, for the sale and distribution of the nHale^TM. This partnership makes nHale^TM accessible in the Middle East, North Africa, and South Asia (MENASA) region, benefiting patients and health care providers with an affordable, high-quality solution,” said Zarmina Jafar, Head of Strategy at THB Global.

Nanotronics Health, LLC, obtained Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for nHale^TM for use in traditional healthcare facilities, spaces converted for the care of large numbers of COVID-19 patients, and in at-home settings with a doctor’s prescription. This authorization includes the optional use of supplemental oxygen in tandem with nHale™ when a qualified medical professional prescribes it.

Non-invasive ventilation is critical for COVID-19 patient care in the hospital and beyond. To meet this need, Nanotronics Health, LLC, leveraged Nanotronics’ deep in-house expertise, incorporating advanced AI, Intelligent Factory Control (IFC) and sophisticated engineering to conceive, design and manufacture nHale^TM in under 90 days.

“We developed nHale^TM to meet the urgent need for non-invasive respiratory options for patients suffering from COVID-19,” said Julie Orlando, President of Nanotronics Health, LLC. “We designed for quality, comfort and ease of use, making nHale^TM available at a fraction of the cost of other non-invasive ventilators.”

Nanotronics Health, LLC, developed and designed nHale™ to assist spontaneously breathing adults suffering from COVID-19 disease. It is intended for use in non-life-threatening situations, such as a patient in need of breathing assistance but not in need of invasive ventilatory support based on standard medical protocols.

Disclaimer: This content is distributed by Business Wire India.